EDGAR Filing Documents for 0001564590-17-017690

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-17-017690

Filing Date

2017-08-14

Accepted

2017-08-14 17:10:45

Documents

Period of Report

2017-06-30

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	life-10q_20170630.htm	10-Q	1544270
2	EX-4.7	life-ex47_235.htm	EX-4.7	97963
3	EX-4.8	life-ex48_234.htm	EX-4.8	94970
4	EX-10.1	life-ex101_233.htm	EX-10.1	103685
5	EX-31.1	life-ex311_8.htm	EX-31.1	9597
6	EX-31.2	life-ex312_6.htm	EX-31.2	9133
7	EX-32.1	life-ex321_7.htm	EX-32.1	5469
8	EX-32.2	life-ex322_9.htm	EX-32.2	5512
	Complete submission text file	0001564590-17-017690.txt		5383070

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	life-20170630.xml	EX-101.INS	1158202
10	XBRL TAXONOMY EXTENSION SCHEMA	life-20170630.xsd	EX-101.SCH	32341
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	life-20170630_cal.xml	EX-101.CAL	33767
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	life-20170630_def.xml	EX-101.DEF	118523
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE	life-20170630_lab.xml	EX-101.LAB	264380
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	life-20170630_pre.xml	EX-101.PRE	198230

Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121

Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389

aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 171031479
SIC: 2836 Biological Products, (No Diagnostic Substances)